Therefore, the expressions of ZO-1 and occludin in the gut, which were reduced by HDF, were restored by DZD, thereby mitigating the loss of intestinal barrier integrity in the NAFLD model. The gene discussed is OCLN; the disease is metabolic dysfunction-associated steatotic liver disease.